BioSpace News Archive

Deals

Transoma Medical Sees IPO Priced at $14-$16 Each

January 15, 2008
·
1 min read
Deals

Whatman Plc Confirms That It Has Received Preliminary Approaches to Acquire the Company

January 15, 2008
·
1 min read
Business

Molecular Partners AG Collaborates with Centocor Research And Development, Inc.

January 15, 2008
·
2 min read
Business

Genentech, Inc.'s Avastin Disappoints Company Earnings

January 15, 2008
·
1 min read
Drug Development

Roche Responds to Announcement of ‘IDEAL’ Hepatitis C Trial Results

January 15, 2008
·
9 min read
Drug Development

Arpida, Inc. Receives Green Light From US FDA for Phase II Efficacy Trial With Oral Iclaprim

January 15, 2008
·
4 min read
Deals

Three Rivers Pharmaceuticals, LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals International for $91M

January 15, 2008
·
1 min read
Drug Development

Anthera Pharmaceuticals, Inc. Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial

January 15, 2008
·
2 min read
Business

Strativa Pharmaceuticals Acquires Commercialization Rights to Onconase(R) from Alfacell

January 15, 2008
·
4 min read
Drug Development

KOSAN Biosciences, Inc. Initiates Phase 2 Trial of Alvespimycin, Second-Generation Hsp90 Inhibitor, in HER2-Positive Metastatic Breast Cancer

January 15, 2008
·
6 min read